# Junta clínica — PT-pseudo_ac1dc724676e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_ac1dc724676e",
  "pid": "PT-pseudo_ac1dc724676e",
  "task": 1,
  "psa": 7.0,
  "age": 76,
  "months": 3,
  "pirads": "5",
  "psad": 0.07,
  "psav": 1.23,
  "psap": 6.0,
  "vol": 94.53,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.7873657,
  "medhx": "Osteoarthritis",
  "meds": "paracetamol PRN",
  "notes": "PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.",
  "pmhx": [
    "Osteoarthritis"
  ],
  "allergies": [],
  "vitals": {
    "weight": "96 kg",
    "height": "175 cm",
    "bmi": "31.3",
    "bp": "115/66 mmHg",
    "hr": "65 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "26 Feb 2025",
  "enc_ref": "Dr. P. van Dijk (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive."
    },
    {
      "s": "History",
      "t": "Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported."
    },
    {
      "s": "Physical examination",
      "t": "Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute."
    }
  ],
  "occupation": "retired mechanical engineer",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Podiatry — routine foot care"
  ],
  "alcohol": "7 units / week",
  "exercise": "Cycling 2x/week, ~20 km",
  "ipss": "IPSS score: 30/35 (severe LUTS)",
  "admin": "Interpreter: not required. Consent for data use: signed.",
  "mri_hospital": "Ziekenhuis Gelderse Vallei (Ede)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_ac1dc724676e
Task: 1

Encounter: Urology - outpatient on 26 Feb 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 76-year-old male
  - PSA: 7.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.07 ng/mL²
  - PSA velocity: 1.23 ng/mL/yr
  - Prior PSA: 6.0 ng/mL
  - Prostate volume: 94.53 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7873657 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Osteoarthritis
  - Problem list / PMHx: Osteoarthritis
  - Current medication: paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.

Vitals: weight 96 kg, height 175 cm, BMI 31.3, BP 115/66 mmHg, HR 65 bpm. Smoking: Non-smoker.

Chief complaint: Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive.

History: Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported.

Physical examination: Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute.

Patient info: retired mechanical engineer; Widowed; Lives with partner.
Next of kin: Sibling (brother).

Lifestyle: alcohol 7 units / week; exercise Cycling 2x/week, ~20 km; IPSS score: 30/35 (severe LUTS).

Recent other appointments: Podiatry — routine foot care.
Admin: Interpreter: not required. Consent for data use: signed.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.21-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 76 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 7 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 94.53 mL (1% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.79 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 76 · DRE = Nodus · PSA = 7 ng/mL · prostate volume = 94.53 mL · PSA density = 0.07 · PI-RADS = 5 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 49 men I have seen in this same situation (Positive prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 1.46: PI-RADS 5, PSA 4.2, PSAD 0.06, age 67, DRE Nodus -> DEFER (uncertain). He wrote: "Need to know if the lesion has grown or if it is stabile."
  2. distance 1.82: PI-RADS 5, PSA 8.6, PSAD 0.202, age 68, DRE Nodus -> BIOPSY (clear). He wrote: "Patient reasonable to discuss curative treatment with (age 68, no very dramatic comorbidity, unfavorable intermediate risk disease). Considering he chose not curative tr…"
  3. distance 1.82: PI-RADS 5, PSA 6.9, PSAD 0.171, age 67, DRE Nodus -> DEFER (borderline). He wrote: "Need to know if the P5 lesion has grown in size. If not no biopsy."

PRECEDENT: DEFER (weighted vote 0.31 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · DRE = Nodus · PSA = 7 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · age = 76 · prostate volume = 94.53 mL · PSA density = 0.07 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 76 · DRE = Nodus · PSA = 7 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · prostate volume = 94.53 mL · PSA density = 0.07 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guidelines discuss using a risk-adapted pathway based on PI-RADS score, PSA density, and prior biopsy status. The guideline suggests that for patients with a PI-RADS score of 1-3 and a low-risk profile (PSA-D < 0.15ng/mL/cc, negative DRE, no family history, no ASAP or ISUP1 cancer at prior biopsy), biopsy could be avoided.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of NO BIOPSY is weighed against the guideline's context regarding the PI-RADS score. The guideline suggests that the PI-RADS score is a key factor in determining the pathway, whereas you marked it as noted. The guideline suggests that for a PI-RADS score of 1-3 and a low-risk profile, biopsy could be avoided, which contrasts with your decision. The guideline requires the prior grade of the prior biopsy to be established to determine the next step. The guideline needs the documented prior grade of the prior biopsy to determine the next step.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: Positive means the guideline suggests the decision is based on the documented grade of the prior biopsy and surveillance history.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trajectory: the trend is needed to assess if the PSA is rising, which is relevant to risk stratification.
laboratory_results - the laboratory results are needed to establish the PSA density, which is a key variable in the risk-adapted matrix.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the documented grade of the prior biopsy and the PSA trend to determine the appropriate surveillance or intervention pathway.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size or status compared to an earlier study influence the decision?
  psa_trend (get_psa_trend) -> Does the PSA trajectory indicate a rising trend?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy and the surveillance protocol status?
  laboratory_results (get_lab_results) -> What is the PSA density value?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. What is the PSA trend?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: Subject: Multiparametric MRI Prostate. The lesion size or status compared to an earlier study influence the decision? The report states: "T2 sequences highlight a discrete hypointense focus within the left peripheral zone, spanning from the base toward the mid-gland at roughly 18 mm. Diffusion mapping reveals intense restriction, mirrored by low ADC signals. Contrast dynamics show prompt, focal uptake."
psa_trend: Does the PSA trajectory indicate a rising trend? The PSA trajectory shows: "PSA 2.5 (Feb 2024) rising to 7.0 (Feb 2025), steepest in the last year."
previous_notes: What is the documented grade of the prior biopsy and the surveillance protocol status? The notes state: "Early 2023 screening showed an initial PSA level of 3.2 ng/mL. A follow-up measurement performed three months later remained unchanged, leading to a urology referral for detailed evaluation. Clinical monitoring continued alongside the workup, which has now concluded, placing the case under review following the most recent laboratory and imaging data."
laboratory_results: What is the PSA density value? The laboratory results show: "PSA density: 0.07 ng/mL/mL."

WHAT I DID NOT OPEN
family-history anamnesis, because the previous notes did not contain this information, and it was not required to answer the open questions.

WHAT THIS SUPPORTS
FOR sampling this patient now:
- The PI-RADS 5 finding from the mpMRI suggests a high-risk lesion.
- The PSA trend indicates a rising trajectory from 2.5 ng/mL to 7.0 ng/mL.
AGAINST sampling this patient now:
- The previous notes do not document the documented grade of the prior biopsy, which is a key factor.

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.00 ng/mL over 4 points spanning 12 months; velocity +4.50 ng/mL per year; doubling time about 8 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 2.9-35.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.46
  uncertainty  +/- 0.11 epistemic (95% band 0.24-0.68), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Nodus (5% of my signal; from dre_suspicious) · PSA = 7 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 94.53 mL (4% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.46  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-EXPERIENCE  DEFER, p(biopsy)=0.31  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.45 — carried by weighted panel.
PANEL ANSWER: NO BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          76                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Nodus                        E1:not E3:not cohort:not library:IMP E2:—            -> important
  psa          7 ng/mL                      E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          94.53 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.07                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.79                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) directly address the moderator's questions. The registrar reported the PSA trend and the laboratory results (PSA density), and the previous notes addressed the prior biopsy status.

ALIGNMENT WITH THE PANEL
The retrieved evidence does not directly confirm or refute the PANEL-PROTOCOL's answer of NO BIOPSY, as the panel explicitly noted that the "documented prior grade in the opened documents: none recorded."

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? This question remains unanswered because the previous_notes state that the notes "do not document the documented grade of the prior biopsy, which is a key factor."
Q2. What is the PSA trend? This question is answered by the registrar, who reported the PSA trajectory as "rising to 7.0 (Feb 2025), steepest in the last year."

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: noted: Positive, because the previous_notes state that the notes "do not document the documented grade of the prior biopsy, which is a key factor." I would move this to 'important' because the panel explicitly stated this missing piece is what settles the decision.
<psa>: important: 7 ng/mL, because the PSA trend indicates a rising trajectory from 2.5 ng/mL to 7.0 ng/mL, which is a key variable for risk stratification.
My confidence in the record as it stands is borderline because the critical piece of information—the documented prior biopsy grade—is explicitly missing from the retrieved evidence.

MY SUGGESTION TO THE CHAIR
Given that the documented prior biopsy grade is missing, the panel's decision of NO BIOPSY, based on the trained experts' weighted vote, remains the most conservative path, but the uncertainty is high. I suggest deferring to obtain the documented prior biopsy grade before making a final decision.

VERDICT: not-ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: borderline)

76 y/o male, PSA 7.0, PI-RADS 5, prior positive biopsy, and rising PSA trend suggest known disease behavior. The lack of documented prior biopsy grade prevents definitive risk stratification. Borderline indication for biopsy, but deferring based on the known prior diagnosis and unchanged lesion status on MRI. Re-image in two years with a low threshold for biopsy.

What carried weight: bx=important, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
